Search Results

There are 1637 results for: content related to: Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages

  1. You have free access to this content
    Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets

    Oral Diseases

    Volume 21, Issue 1, January 2015, Pages: e25–e50, F Ahmad, T Murata, K Shimizu, E Degerman, D Maurice and V Manganiello

    Article first published online : 12 SEP 2014, DOI: 10.1111/odi.12275

  2. You have free access to this content
    Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease

    British Journal of Pharmacology

    Volume 157, Issue 6, July 2009, Pages: 892–906, Katharine H Banner and Neil J Press

    Article first published online : 5 JUN 2009, DOI: 10.1111/j.1476-5381.2009.00170.x

  3. You have free access to this content
    Inotropy and L-type Ca2+ current, activated by β1- and β2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart

    British Journal of Pharmacology

    Volume 156, Issue 1, January 2009, Pages: 62–83, Torsten Christ, Alejandro Galindo-Tovar, Marcus Thoms, Ursula Ravens and Alberto J. Kaumann

    Article first published online : 24 DEC 2008, DOI: 10.1111/j.1476-5381.2008.00015.x

  4. You have free access to this content
    Differential regulation of β2-adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle

    British Journal of Pharmacology

    Volume 162, Issue 1, January 2011, Pages: 54–71, Faraz Afzal, Jan Magnus Aronsen, Lise Román Moltzau, Ivar Sjaastad, Finn Olav Levy, Tor Skomedal, Jan-Bjørn Osnes and Eirik Qvigstad

    Article first published online : 25 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00890.x

  5. You have free access to this content
    Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4

    British Journal of Pharmacology

    Volume 171, Issue 23, December 2014, Pages: 5361–5375, F Hubert, M Belacel-Ouari, B Manoury, K Zhai, V Domergue-Dupont, P Mateo, F Joubert, R Fischmeister and V Leblais

    Article first published online : 24 NOV 2014, DOI: 10.1111/bph.12853

  6. You have free access to this content
    Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases

    Basic & Clinical Pharmacology & Toxicology

    Volume 114, Issue 5, May 2014, Pages: 365–376, Katharine H. Abbott-Banner and Clive P. Page

    Article first published online : 6 MAR 2014, DOI: 10.1111/bcpt.12209

  7. You have free access to this content
    Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT4 receptors

    British Journal of Pharmacology

    Volume 156, Issue 2, January 2009, Pages: 237–249, Alejandro Galindo-Tovar, Maria Luisa Vargas, Elisa Escudero and Alberto J. Kaumann

    Article first published online : 21 JAN 2009, DOI: 10.1111/j.1476-5381.2008.00023.x

  8. You have free access to this content
    5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles

    British Journal of Pharmacology

    Volume 155, Issue 7, December 2008, Pages: 1005–1014, F Afzal, K W Andressen, H K Mørk, J M Aronsen, I Sjaastad, C P Dahl, T Skomedal, F O Levy, J-B Osnes and E Qvigstad

    Article first published online : 29 JAN 2009, DOI: 10.1038/bjp.2008.339

  9. You have free access to this content
    Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity

    British Journal of Pharmacology

    Volume 122, Issue 2, September 1997, Pages: 233–240, R. J. Rose, H. Liu, D. Palmer and D. H. Maurice

    Article first published online : 5 FEB 2009, DOI: 10.1038/sj.bjp.0701376

  10. Inhibitory effects of hesperetin derivatives on guinea pig phosphodiesterases and Their ratios between high- and low-affinity rolipram binding

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 7, July 2013, Pages: 2120–2127, Hsin-Te Hsu, Wen-Hung Wang, Cheng-Ying Han, Chun-Nan Chen, Chi-Ming Chen and Wun-Chang Ko

    Article first published online : 10 MAY 2013, DOI: 10.1002/jps.23591

  11. You have free access to this content
    Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments

    British Journal of Pharmacology

    Volume 165, Issue 5, March 2012, Pages: 1288–1305, Thérèse Keravis and Claire Lugnier

    Article first published online : 10 FEB 2012, DOI: 10.1111/j.1476-5381.2011.01729.x

  12. ONIOM investigation of nucleotide selectivity in phosphodiesterases 3 and 4

    International Journal of Quantum Chemistry

    Volume 108, Issue 6, 2008, Pages: 1189–1199, E. A. Salter, Kerrie A. O'Brien, R. Wesley Edmunds and A. Wierzbicki

    Article first published online : 10 JAN 2008, DOI: 10.1002/qua.21589

  13. You have free access to this content
    Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system

    British Journal of Pharmacology

    Volume 148, Issue 6, July 2006, Pages: 833–844, Ying Zhu, Jian Yao, Yiman Meng, Ayumi Kasai, Nobuhiko Hiramatsu, Kunihiro Hayakawa, Takashi Miida, Masayuki Takeda, Masahiko Okada and Masanori Kitamura

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706785

  14. You have free access to this content
    Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart

    British Journal of Pharmacology

    Volume 171, Issue 23, December 2014, Pages: 5169–5181, Ø Ørstavik, S H Ata, J Riise, C P Dahl, G Ø Andersen, F O Levy, T Skomedal, J-B Osnes and E Qvigstad

    Article first published online : 24 NOV 2014, DOI: 10.1111/bph.12647

  15. You have free access to this content
    The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C4-induced contractions in passively sensitized human airways

    British Journal of Pharmacology

    Volume 131, Issue 8, December 2000, Pages: 1607–1618, Dunja T Schmidt, Nikki Watson, Gordon Dent, Elke Rühlmann, Detlev Branscheid, Helgo Magnussen and Klaus F Rabe

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703725

  16. You have free access to this content
    Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells

    British Journal of Pharmacology

    Volume 142, Issue 2, May 2004, Pages: 339–351, Malcolm C Shepherd, George S Baillie, David I Stirling and Miles D Houslay

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705770

  17. You have free access to this content
    Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following β2-adrenergic stimulation of ICa,L in frog ventricular myocytes

    The Journal of Physiology

    Volume 551, Issue 1, August 2003, Pages: 239–252, Jonas Jurevicius, V. Arvydas Skeberdis and Rodolphe Fischmeister

    Article first published online : 16 JUL 2004, DOI: 10.1111/j.1469-7793.2003.00239.x

  18. PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization

    International Journal of Experimental Pathology

    Volume 90, Issue 6, December 2009, Pages: 605–614, Rima Tahseldar-Roumieh, Thérèse Keravis, Suha Maarouf, Hélène Justiniano, Ramzi Sabra and Claire Lugnier

    Article first published online : 15 SEP 2009, DOI: 10.1111/j.1365-2613.2009.00678.x

  19. You have free access to this content
    Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (−)-adrenaline mediated through mouse cardiac β1-adrenoceptors

    British Journal of Pharmacology

    Volume 153, Issue 4, February 2008, Pages: 710–720, A Galindo-Tovar and A J Kaumann

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707631

  20. Selective phosphodiesterase inhibitors for the treatment of bronchial asthma and chronic obstructive pulmonary disease

    Clinical & Experimental Allergy

    Volume 29, Issue s2, June 1999, Pages: 99–109, D. Schmidt, G. Dent and K. F. Rabe

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2222.1999.00018.x